Investigating the response of paediatric leukaemia‐propagating cells to BCL‐2 inhibitors-Reference-Cited by-同舟云学术

Investigating the response of paediatric leukaemia‐propagating cells to BCL‐2 inhibitors

Published:2020-05-25 Issue:3 Volume:192 Page:577-588
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Diamanti Paraskevi¹²,Ede Benjamin C.²,Dace Phoebe EI²,Barendt William J.²,Cox Charlotte V.¹,Hancock Jeremy P.³,Moppett John P.²⁴,Blair Allison¹²^ORCID

Affiliation:

1. Bristol Institute for Transfusion Sciences NHSBT Filton BristolUK

2. School of Cellular and Molecular Medicine University of Bristol BristolUK

3. Bristol Genetics Laboratory Severn Pathology, North Bristol Trust Bristol UK

4. Bristol Royal Hospital for Children Bristol UK

Funder

Programme Grants for Applied Research

National Institute for Health Research

NHS Blood and Transplant

University of Bristol

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.16773

Reference49 articles.

1. Childhood Acute Lymphoblastic Leukemia: Progress Through Collaboration

2. Outcome of Patients Treated for Relapsed or Refractory Acute Lymphoblastic Leukemia: A Therapeutic Advances in Childhood Leukemia Consortium Study

3. Outcomes after Induction Failure in Childhood Acute Lymphoblastic Leukemia

4. Improvement of the Outcome of Relapsed or Refractory Acute Lymphoblastic Leukemia in Children Using a Risk-Based Treatment Strategy

5. Relapse in children with acute lymphoblastic leukemia involving selection of a preexisting drug-resistant subclone

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent Updates in Venetoclax Combination Therapies in Pediatric Hematological Malignancies;International Journal of Molecular Sciences;2023-11-24

2. Synergistic activity of combined inhibition of anti-apoptotic molecules in B-cell precursor ALL;Leukemia;2022-01-14

3. Targeting pediatric leukemia-propagating cells with anti-CD200 antibody therapy;Blood Advances;2021-09-01